{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T23:11:31Z","timestamp":1772838691806,"version":"3.50.1"},"reference-count":104,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2016,12,10]],"date-time":"2016-12-10T00:00:00Z","timestamp":1481328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Acute myeloid leukemia (AML) is caused by malignant transformation of hematopoietic stem or progenitor cells and displays the most frequent acute leukemia in adults. Although some patients can be cured with high dose chemotherapy and allogeneic hematopoietic stem cell transplantation, the majority still succumbs to chemoresistant disease. Micro-RNAs (miRNAs) and long non-coding RNAs (lncRNAs) are non-coding RNA fragments and act as key players in the regulation of both physiologic and pathologic gene expression profiles. Aberrant expression of various non-coding RNAs proved to be of seminal importance in the pathogenesis of AML, as well in the development of resistance to chemotherapy. In this review, we discuss the role of miRNAs and lncRNAs with respect to sensitivity and resistance to treatment regimens currently used in AML and provide an outlook on potential therapeutic targets emerging thereof.<\/jats:p>","DOI":"10.3390\/ijms17122080","type":"journal-article","created":{"date-parts":[[2016,12,12]],"date-time":"2016-12-12T14:43:57Z","timestamp":1481553837000},"page":"2080","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs"],"prefix":"10.3390","volume":"17","author":[{"given":"Armin","family":"Zebisch","sequence":"first","affiliation":[{"name":"Division of Hematology, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Hatzl","sequence":"additional","affiliation":[{"name":"Division of Hematology, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8701-9462","authenticated-orcid":false,"given":"Martin","family":"Pichler","sequence":"additional","affiliation":[{"name":"Division of Oncology, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"W\u00f6lfler","sequence":"additional","affiliation":[{"name":"Division of Hematology, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"Sill","sequence":"additional","affiliation":[{"name":"Division of Hematology, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2016,12,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute Myeloid Leukemia","volume":"373","author":"Dohner","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1476-5381.2010.01100.x","article-title":"Therapy-Related Myeloid Neoplasms: Pathobiology and Clinical Characteristics","volume":"162","author":"Sill","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2174\/092986707780059670","article-title":"Signaling through RAS-RAF-MEK-ERK: From Basics to Bedside","volume":"14","author":"Zebisch","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/jmedgenet-2011-100674","article-title":"Germline Mutations in the DNA Damage Response Genes BRCA1, BRCA2, BARD1 and TP53 in Patients with Therapy Related Myeloid Neoplasms","volume":"49","author":"Schulz","year":"2012","journal-title":"J. Med. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/leu.2009.68","article-title":"Loss of RAF Kinase Inhibitor Protein is a Somatic Event in the Pathogenesis of Therapy-Related Acute Myeloid Leukemias with C-RAF Germline Mutations","volume":"23","author":"Zebisch","year":"2009","journal-title":"Leukemia"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1182\/blood-2011-12-379008","article-title":"Acute Myeloid Leukemia in the Real World: Why population-based registries are needed","volume":"119","author":"Juliusson","year":"2012","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","article-title":"Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet","volume":"115","author":"Dohner","year":"2010","journal-title":"Blood"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-016-0237-y","article-title":"A Clinical-Molecular Update on Azanucleoside-Based Therapy for the Treatment of Hematologic Cancers","volume":"8","author":"Diesch","year":"2016","journal-title":"Clin. Epigenet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.leukres.2016.01.014","article-title":"Infections in Patients with Acute Myeloid Leukemia Treated with Low-Intensity Therapeutic Regimens: Risk Factors and Efficacy of Antibiotic Prophylaxis","volume":"42","author":"Bainschab","year":"2016","journal-title":"Leuk. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/leu.2011.317","article-title":"How to Manage High-Risk Acute Myeloid Leukemia","volume":"26","author":"Estey","year":"2012","journal-title":"Leukemia"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1182\/blood-2016-08-732610","article-title":"Acute Myeloid Leukemia with TP53 Germline Mutations","volume":"128","author":"Zebisch","year":"2016","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1182\/blood-2008-07-172007","article-title":"Age and Acute Myeloid Leukemia: Real World Data on Decision to Treat and Outcomes from the Swedish Acute Leukemia Registry","volume":"113","author":"Juliusson","year":"2009","journal-title":"Blood"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature10738","article-title":"Clonal Evolution in Relapsed Acute Myeloid Leukaemia Revealed by Whole-Genome Sequencing","volume":"481","author":"Ding","year":"2012","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nrd4140","article-title":"MicroRNAs and Other Non-Coding RNAs as Targets for Anticancer Drug Development","volume":"12","author":"Ling","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1038\/onc.2014.456","article-title":"Junk DNA and the Long Non-Coding RNA Twist in Cancer Genetics","volume":"34","author":"Ling","year":"2015","journal-title":"Oncogene"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/bjc.2015.253","article-title":"MicroRNAs in Cancer: From Developmental Genes in Worms to their Clinical Application in Patients","volume":"113","author":"Pichler","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent Deletions and Down-Regulation of Micro-RNA Genes miR15 and miR16 at 13q14 in Chronic Lymphocytic Leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/leu.2011.151","article-title":"MicroRNAs in Acute Leukemia: From Biological Players to Clinical Contributors","volume":"26","author":"Schotte","year":"2012","journal-title":"Leukemia"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/leu.2015.253","article-title":"Prognostic Significance of NPM1 Mutation-Modulated microRNA-mRNA Regulation in Acute Myeloid Leukemia","volume":"30","author":"Chiu","year":"2016","journal-title":"Leukemia"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrc3318","article-title":"MicroRNAs in the p53 Network: Micromanagement of Tumour Suppression","volume":"12","author":"Hermeking","year":"2012","journal-title":"Nat. Rev. Cancer."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1158\/0008-5472.CAN-15-3049","article-title":"Increased Expression of miR-23a Mediates a Loss of Expression in the RAF Kinase Inhibitor Protein RKIP","volume":"76","author":"Hatzl","year":"2016","journal-title":"Cancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1182\/blood-2008-01-133355","article-title":"MicroRNA Expression Profiling in Relation to the Genetic Heterogeneity of Acute Myeloid Leukemia","volume":"111","author":"Sun","year":"2008","journal-title":"Blood"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/leu.2014.231","article-title":"NF-\u03baB\/STAT5\/miR-155 Network Targets PU.1 in FLT3-ITD-Driven Acute Myeloid Leukemia","volume":"29","author":"Gerloff","year":"2015","journal-title":"Leukemia"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrclinonc.2012.150","article-title":"The European LeukemiaNet AML Working Party Consensus Statement on Allogeneic HSCT for Patients with AML in Remission: An Integrated-Risk Adapted Approach","volume":"9","author":"Cornelissen","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa074256","article-title":"MicroRNA Expression in Cytogenetically Normal Acute Myeloid Leukemia","volume":"358","author":"Marcucci","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1200\/JCO.2010.29.2953","article-title":"Prognostic Significance of Expression of a Single microRNA, miR-181a, in Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study","volume":"28","author":"Schwind","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1182\/blood-2011-10-386235","article-title":"Up-Regulation of a HOXA-PBX3 Homeobox-Gene Signature Following Down-Regulation of miR-181 is Associated with Adverse Prognosis in Patients with Cytogenetically Abnormal AML","volume":"119","author":"Li","year":"2012","journal-title":"Blood"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.3109\/10428194.2013.847936","article-title":"MicroRNA Let-7f is Down-Regulated in Patients with Refractory Acute Myeloid Leukemia and is Involved in Chemotherapy Resistance of Adriamycin-Resistant Leukemic Cells","volume":"55","author":"Dai","year":"2014","journal-title":"Leuk. Lymphoma"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/leu.2015.282","article-title":"Expression of a Passenger miR-9* Predicts Favorable Outcome in Adults with Acute Myeloid Leukemia Less than 60 Years of Age","volume":"30","author":"Nowek","year":"2016","journal-title":"Leukemia"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1746-1596-9-76","article-title":"Prognostic Value of miR-96 in Patients with Acute Myeloid Leukemia","volume":"9","author":"Zhao","year":"2014","journal-title":"Diagn. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/leu.2013.281","article-title":"MicroRNA Expression at Diagnosis Adds Relevant Prognostic Information to Molecular Categorization in Patients with Intermediate-Risk Cytogenetic Acute Myeloid Leukemia","volume":"28","author":"Brunet","year":"2014","journal-title":"Leukemia"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1182\/blood-2013-10-532374","article-title":"Implications of the miR-10 Family in Chemotherapy Response of NPM1-Mutated AML","volume":"123","author":"Havelange","year":"2014","journal-title":"Blood"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00277-013-1729-x","article-title":"The Clinical Characteristics and Prognostic Significance of MN1 Gene and MN1-Associated microRNA Expression in Adult Patients with De Novo Acute Myeloid Leukemia","volume":"92","author":"Xiang","year":"2013","journal-title":"Ann. Hematol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1200\/JCO.2012.45.6228","article-title":"Clinical Role of microRNAs in Cytogenetically Normal Acute Myeloid Leukemia: MiR-155 Upregulation Independently Identifies High-Risk Patients","volume":"31","author":"Marcucci","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/leu.2014.333","article-title":"A 3-microRNA Scoring System for Prognostication in De Novo Acute Myeloid Leukemia Patients","volume":"29","author":"Chuang","year":"2015","journal-title":"Leukemia"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-10-108","article-title":"Upregulation of microRNA-125b Contributes to Leukemogenesis and Increases Drug Resistance in Pediatric Acute Promyelocytic Leukemia","volume":"10","author":"Zhang","year":"2011","journal-title":"Mol. Cancer."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.3892\/mmr.2014.2011","article-title":"MicroRNA125b Promotes Leukemia Cell Resistance to Daunorubicin by Inhibiting Apoptosis","volume":"9","author":"Zhou","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1158\/0008-5472.CAN-13-1733","article-title":"Attenuation of microRNA-126 Expression that Drives CD34+38\u2212 stem\/progenitor Cells in Acute Myeloid Leukemia Leads to Tumor Eradication","volume":"74","author":"Denkers","year":"2014","journal-title":"Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1038\/leu.2015.139","article-title":"Targeting Leukemia Stem Cells in Vivo with antagomiR-126 Nanoparticles in Acute Myeloid Leukemia","volume":"29","author":"Dorrance","year":"2015","journal-title":"Leukemia"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ccell.2015.12.011","article-title":"MiR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells","volume":"29","author":"Lechman","year":"2016","journal-title":"Cancer Cell"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.12659\/MSM.894812","article-title":"Overexpression of miR-210 is Associated with Poor Prognosis of Acute Myeloid Leukemia","volume":"21","author":"Tang","year":"2015","journal-title":"Med. Sci. Monit."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1182\/blood-2012-02-408492","article-title":"MiR-3151 Interplays with its Host Gene BAALC and Independently Affects Outcome of Patients with Cytogenetically Normal Acute Myeloid Leukemia","volume":"120","author":"Eisfeld","year":"2012","journal-title":"Blood"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e352","DOI":"10.1038\/bcj.2015.76","article-title":"The Expression Level of BAALC-Associated microRNA miR-3151 is an Independent Prognostic Factor in Younger Patients with Cytogenetic Intermediate-Risk Acute Myeloid Leukemia","volume":"5","author":"Brunet","year":"2015","journal-title":"Blood Cancer. J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood-2007-07-098749","article-title":"MicroRNA Signatures Associated with Cytogenetics and Prognosis in Acute Myeloid Leukemia","volume":"111","author":"Garzon","year":"2008","journal-title":"Blood"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.febslet.2015.04.061","article-title":"Long Non-Coding RNA HOTAIR Modulates c-KIT Expression through Sponging miR-193a in Acute Myeloid Leukemia","volume":"589","author":"Xing","year":"2015","journal-title":"FEBS Lett."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.3892\/ol.2015.3552","article-title":"Overexpression of Long Non-Coding RNA HOTAIR Predicts a Poor Prognosis in Patients with Acute Myeloid Leukemia","volume":"10","author":"Wu","year":"2015","journal-title":"Oncol. Lett."},{"key":"ref_47","first-page":"7223","article-title":"HOTAIR is Upregulated in Acute Myeloid Leukemia and that Indicates a Poor Prognosis","volume":"8","author":"Hao","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"31613","DOI":"10.18632\/oncotarget.5148","article-title":"The lincRNA HOTAIRM1, Located in the HOXA Genomic Region, is Expressed in Acute Myeloid Leukemia, Impacts Prognosis in Patients in the Intermediate-Risk Cytogenetic Category, and is Associated with a Distinctive microRNA Signature","volume":"6","author":"Brunet","year":"2015","journal-title":"Oncotarget"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/abbs\/gmr128","article-title":"MiR-181a Sensitizes a Multidrug-Resistant Leukemia Cell Line K562\/A02 to Daunorubicin by Targeting BCL-2","volume":"44","author":"Li","year":"2012","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00432-011-1137-3","article-title":"MiR-181a Sensitizes Resistant Leukaemia HL-60\/Ara-C Cells to Ara-C by Inducing Apoptosis","volume":"138","author":"Bai","year":"2012","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1172\/JCI66553","article-title":"CXCR4 Downregulation of Let-7a Drives Chemoresistance in Acute Myeloid Leukemia","volume":"123","author":"Chen","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"492","DOI":"10.2174\/1389201015666140519122524","article-title":"Effect of miR-128 in DNA Damage of HL-60 Acute Myeloid Leukemia Cells","volume":"15","author":"Seca","year":"2014","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1111\/j.1582-4934.2010.01213.x","article-title":"Down-Regulated miR-331\u20135p and miR-27a are Associated with Chemotherapy Resistance and Relapse in Leukaemia","volume":"15","author":"Feng","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"6230","DOI":"10.1158\/0008-5472.CAN-11-1717","article-title":"MicroRNA-32 Upregulation by 1,25-Dihydroxyvitamin D3 in Human Myeloid Leukemia Cells Leads to Bim Targeting and Inhibition of AraC-Induced Apoptosis","volume":"71","author":"Gocek","year":"2011","journal-title":"Cancer Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.3892\/or.2015.3839","article-title":"Upregulation of microRNA-126\u20135p is Associated with Drug Resistance to Cytarabine and Poor Prognosis in AML Patients","volume":"33","author":"Shibayama","year":"2015","journal-title":"Oncol. Rep."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1158\/0008-5472.CAN-13-1748","article-title":"Inhibition of miR-17 and miR-20a by Oridonin Triggers Apoptosis and Reverses Chemoresistance by Derepressing BIM-S","volume":"74","author":"Weng","year":"2014","journal-title":"Cancer Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/leu.2012.356","article-title":"The Role of HOX Genes in Normal Hematopoiesis and Acute Leukemia","volume":"27","author":"Alharbi","year":"2013","journal-title":"Leukemia"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1182\/blood-2012-05-428573","article-title":"Lenalidomide-Mediated Enhanced Translation of C\/EBP\u03b1-p30 Protein Up-Regulates Expression of the Antileukemic microRNA-181a in Acute Myeloid Leukemia","volume":"121","author":"Hickey","year":"2013","journal-title":"Blood"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/35002607","article-title":"The 21-Nucleotide Let-7 RNA Regulates Developmental Timing in Caenorhabditis Elegans","volume":"403","author":"Reinhart","year":"2000","journal-title":"Nature"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.leukres.2013.09.022","article-title":"Overexpressed Let-7a-3 is Associated with Poor Outcome in Acute Myeloid Leukemia","volume":"37","author":"Li","year":"2013","journal-title":"Leuk. Res."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Jinlong, S., Lin, F., Yonghui, L., Li, Y., and Weidong, W. (2015). Identification of Let-7a-2-3p or\/and miR-188-5p as Prognostic Biomarkers in Cytogenetically Normal Acute Myeloid Leukemia. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0118099"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s13238-015-0212-y","article-title":"Biogenesis and Regulation of the Let-7 miRNAs and their Functional Implications","volume":"7","author":"Lee","year":"2016","journal-title":"Protein Cell"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2217\/bmm.14.112","article-title":"Expression of microRNA-331 can be used as a Predictor for Response to Therapy and Survival in Acute Myeloid Leukemia Patients","volume":"9","author":"Butrym","year":"2015","journal-title":"Biomark. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1073\/pnas.0800135105","article-title":"Distinctive microRNA Signature of Acute Myeloid Leukemia Bearing Cytoplasmic Mutated Nucleophosmin","volume":"105","author":"Garzon","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/ajh.21667","article-title":"Differential Expression of Specific microRNA and their Targets in Acute Myeloid Leukemia","volume":"85","author":"Cammarata","year":"2010","journal-title":"Am. J. Hematol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/1756-8722-6-21","article-title":"Silvestrol Exhibits Significant in Vivo and in Vitro Antileukemic Activities and Inhibits FLT3 and miR-155 Expressions in Acute Myeloid Leukemia","volume":"6","author":"Alachkar","year":"2013","journal-title":"J. Hematol. Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/leu.2015.106","article-title":"Pharmacological Targeting of miR-155 Via the NEDD8-Activating Enzyme Inhibitor MLN4924 (Pevonedistat) in FLT3-ITD Acute Myeloid Leukemia","volume":"29","author":"Khalife","year":"2015","journal-title":"Leukemia"},{"key":"ref_68","first-page":"361","article-title":"Screening for Drug Resistance Related microRNAs in K562 and K562\/A02 Cell Lines","volume":"31","author":"Cao","year":"2010","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-13-79","article-title":"MicroRNA-155 as an Inducer of Apoptosis and Cell Differentiation in Acute Myeloid Leukaemia","volume":"13","author":"Palma","year":"2014","journal-title":"Mol. Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1038\/leu.2012.90","article-title":"MiR-125 in Normal and Malignant Hematopoiesis","volume":"26","author":"Shaham","year":"2012","journal-title":"Leukemia"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"15535","DOI":"10.1073\/pnas.0808266105","article-title":"Distinct microRNA Expression Profiles in Acute Myeloid Leukemia with Common Translocations","volume":"105","author":"Li","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1182\/blood-2015-04-639062","article-title":"Overexpression and Knockout of miR-126 both Promote Leukemogenesis","volume":"126","author":"Li","year":"2015","journal-title":"Blood"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"18679","DOI":"10.1073\/pnas.1422050112","article-title":"Expression and Prognostic Impact of lncRNAs in Acute Myeloid Leukemia","volume":"111","author":"Garzon","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_74","first-page":"151","article-title":"LncRNA HOTAIR: A Master Regulator of Chromatin Dynamics and Cancer","volume":"1856","author":"Bhan","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.cell.2007.05.022","article-title":"Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs","volume":"129","author":"Rinn","year":"2007","journal-title":"Cell"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00280-016-2964-3","article-title":"Long Noncoding RNA HOTAIR is a Prognostic Biomarker and Inhibits Chemosensitivity to Doxorubicin in Bladder Transitional Cell Carcinoma","volume":"77","author":"Shang","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/leu.2014.244","article-title":"Novel Drugs for Older Patients with Acute Myeloid Leukemia","volume":"29","year":"2015","journal-title":"Leukemia"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/cncr.22496","article-title":"A Comparison of Low-Dose Cytarabine and Hydroxyurea with or without all-Trans Retinoic Acid for Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome in Patients Not Considered Fit for Intensive Treatment","volume":"109","author":"Burnett","year":"2007","journal-title":"Cancer"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ccr.2010.03.008","article-title":"Sp1\/NF\u03baB\/HDAC\/miR-29b Regulatory Network in KIT-Driven Myeloid Leukemia","volume":"17","author":"Liu","year":"2010","journal-title":"Cancer Cell"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1182\/blood-2008-07-170589","article-title":"MicroRNA-29b Induces Global DNA Hypomethylation and Tumor Suppressor Gene Reexpression in Acute Myeloid Leukemia by Targeting Directly DNMT3A and 3B and Indirectly DNMT1","volume":"113","author":"Garzon","year":"2009","journal-title":"Blood"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1182\/blood-2009-03-211938","article-title":"MicroRNA 29b Functions in Acute Myeloid Leukemia","volume":"114","author":"Garzon","year":"2009","journal-title":"Blood"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.1073\/pnas.1002650107","article-title":"Clinical Response and miR-29b Predictive Significance in Older AML Patients Treated with a 10-Day Schedule of Decitabine","volume":"107","author":"Blum","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1158\/1078-0432.CCR-12-3191","article-title":"Targeted Delivery of microRNA-29b by Transferrin-Conjugated Anionic Lipopolyplex Nanoparticles: A Novel Therapeutic Strategy in Acute Myeloid Leukemia","volume":"19","author":"Huang","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/leu.2012.342","article-title":"Increased Anti-Leukemic Activity of Decitabine via AR-42-Induced Upregulation of miR-29b: A Novel Epigenetic-Targeting Approach in Acute Myeloid Leukemia","volume":"27","author":"Mims","year":"2013","journal-title":"Leukemia"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"30250","DOI":"10.18632\/oncotarget.7172","article-title":"Clinical Response to Azacitidine Therapy Depends on microRNA-29c (miR-29c) Expression in Older Acute Myeloid Leukemia (AML) Patients","volume":"7","author":"Butrym","year":"2016","journal-title":"Oncotarget"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1038\/onc.2011.62","article-title":"MicroRNA-193a Represses C-Kit Expression and Functions as a Methylation-Silenced Tumor Suppressor in Acute Myeloid Leukemia","volume":"30","author":"Gao","year":"2011","journal-title":"Oncogene"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1111\/febs.12485","article-title":"The Epigenetically-Regulated miR-663 Targets H-Ras in K-562 Cells","volume":"280","author":"Yang","year":"2013","journal-title":"FEBS J."},{"key":"ref_88","first-page":"1","article-title":"The Promoter of miR-663 is Hypermethylated in Chinese Pediatric Acute Myeloid Leukemia (AML)","volume":"14","author":"Jian","year":"2013","journal-title":"BMC Med. Genet."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.leukres.2013.12.021","article-title":"miR-125a Regulates Cell Cycle, Proliferation, and Apoptosis by Targeting the ErbB Pathway in Acute Myeloid Leukemia","volume":"38","author":"Ufkin","year":"2014","journal-title":"Leuk. Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1186\/1476-4598-11-56","article-title":"The Tumor Suppressive Role of miRNA-370 by Targeting FoxM1 in Acute Myeloid Leukemia","volume":"11","author":"Zhang","year":"2012","journal-title":"Mol. Cancer."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Wong, K.Y., So, C.C., Loong, F., Chung, L.P., Lam, W.W., Liang, R., Li, G.K., Jin, D.Y., and Chim, C.S. (2011). Epigenetic Inactivation of the miR-124\u20131 in Haematological Malignancies. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0019027"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1111\/j.1582-4934.2011.01274.x","article-title":"Epigenetic Inactivation of the Hsa-miR-203 in Haematological Malignancies","volume":"15","author":"Chim","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1182\/blood-2011-06-362541","article-title":"Allelic Methylation Levels of the Noncoding VTRNA2\u20131 Located on Chromosome 5q31.1 Predict Outcome in AML","volume":"119","author":"Treppendahl","year":"2012","journal-title":"Blood"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/cgt.2014.44","article-title":"The Malignancy Suppression Role of miR-23a by Targeting the BCR\/ABL Oncogene in Chromic Myeloid Leukemia","volume":"21","author":"Xishan","year":"2014","journal-title":"Cancer Gene Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/cas.12339","article-title":"Downregulation of miR-217 Correlates with Resistance of Ph(+) Leukemia Cells to ABL Tyrosine Kinase Inhibitors","volume":"105","author":"Nishioka","year":"2014","journal-title":"Cancer Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ccr.2008.04.018","article-title":"Genetic and Epigenetic Silencing of microRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression","volume":"13","author":"Bueno","year":"2008","journal-title":"Cancer Cell"},{"key":"ref_97","first-page":"1114","article-title":"Combination Chemotherapy of L1210 Leukemia with 1-Beta-D-Arabinofuranosylcytosine and 5-Azacytidine","volume":"36","author":"Neil","year":"1976","journal-title":"Cancer Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0026-895X(25)10880-8","article-title":"Induction of Deoxycytidine Kinase by 5-Azacytidine in an HL-60 Cell Line Resistant to Arabinosylcytosine","volume":"39","author":"Kong","year":"1991","journal-title":"Mol. Pharmacol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1182\/blood-2010-11-320093","article-title":"Phase 1 Study of Epigenetic Priming with Decitabine Prior to Standard Induction Chemotherapy for Patients with AML","volume":"118","author":"Scandura","year":"2011","journal-title":"Blood"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/leu.2015.306","article-title":"Azacitidine in Combination with Intensive Induction Chemotherapy in Older Patients with Acute Myeloid Leukemia: The AML-AZA Trial of the Study Alliance Leukemia","volume":"30","author":"Tschanter","year":"2016","journal-title":"Leukemia"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S1470-2045(15)00038-8","article-title":"Safety and Tolerability of Guadecitabine (SGI-110) in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukaemia: A Multicentre, Randomised, Dose-Escalation Phase 1 Study","volume":"16","author":"Issa","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"33554","DOI":"10.18632\/oncotarget.5591","article-title":"The NF-\u03baB p65\/miR-23a-27a-24 Cluster is a Target for Leukemia Treatment","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1038\/leu.2012.61","article-title":"Frequent Loss of RAF Kinase Inhibitor Protein Expression in Acute Myeloid Leukemia","volume":"26","author":"Zebisch","year":"2012","journal-title":"Leukemia"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4103\/2229-3485.179431","article-title":"MicroRNA Therapeutics: Discovering Novel Targets and Developing Specific Therapy","volume":"7","author":"Christopher","year":"2016","journal-title":"Perspect. Clin. Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/12\/2080\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:28:21Z","timestamp":1760210901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/12\/2080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,10]]},"references-count":104,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12]]}},"alternative-id":["ijms17122080"],"URL":"https:\/\/doi.org\/10.3390\/ijms17122080","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,10]]}}}